Science ventures operate under structural uncertainty and irreversible decision paths that traditional startup logic fails to capture. This article explains why early signals are misleading, why scientific choices cannot be undone, and how capital, governance, and evaluation frameworks must change when value creation depends on resolving unknowns rather than optimizing known risks.